Recurrent

Oncology·MeSH: Neoplasms

240 drugs in development·91 companies·3 clinical trials

Drug Pipeline by Phase

Approved(25)

Drug	Company
apixaban	Mylan II B.V. (MYL)
apixaban	Impax Laboratories, LLC (IPXL)
arcalyst	X4 Pharmaceuticals, Inc (XFOR)
ARCALYST	Kiniksa Pharmaceuticals International, plc (KNSA)
avmapki fakzynja co-pack	Verastem, Inc. (VSTM)
brexafemme	SCYNEXIS INC (SCYX)
butalbital	LANNETT CO INC (LCI)
butalbital	QIAGEN N.V. (QGEN)
butalbital	Optec International, Inc. (GM)
cerianna	GE HealthCare Technologies Inc. (GEHC)
gimoti	Evoke Pharma Inc (EVOK)
Jemperli	ANAPTYSBIO, INC (ANAB)
kyslecel	Orgenesis Inc. (ORGS)
loqtorzi	Coherus Oncology, Inc. (CHRS)
LYMPHIR	Citius Pharmaceuticals, Inc. (CTXR)
LYMPHIR	CITIUS ONCOLOGY, INC. (CTOR)
LYMPHIR (denileukin diftitox-cdxl)	CITIUS ONCOLOGY, INC. (CTOR)
magnesium	EXELIXIS, INC. (EXEL)
mekinist	Novartis AG (NVS)
papzimeos	PRECIGEN, INC. (PGEN)
venlafaxine	Teva Pharmaceutical Industries Limited (TEVA)
VOWST	Seres Therapeutics, Inc. (MCRB)
zejula	TESARO, Inc. (TSRO)
zusduri	UroGen Pharma Ltd. (URGN)
ZYNYZ	MACROGENICS INC (MGNX)

Phase 3(54)

Drug	Company
Apalutamide 60 mg or 240 mg tablets	KYNTRA BIO INC. (KYNB)
Apremilast	Crinetics Pharmaceuticals, Inc. (CRNX)
avutometinib	Merus N.V. (MRUS)
Calaspargase Pegol	AXIM BIOTECHNOLOGIES, INC. (AXIM)
capmatinib	GH Research PLC (GHRS)
cemiplimab	GH Research PLC (GHRS)
Ceralasertib	Relay Therapeutics, Inc. (RLAY)
Ceralasertib	ADMA BIOLOGICS, INC. (ADMA)
Cetuximab	FATE THERAPEUTICS INC (FATE)
chemotherapy	GH Research PLC (GHRS)
chemotherapy	GH Research PLC (GHRS)
Clofarabine	Merus N.V. (MRUS)
Datopotamab Deruxtecan	Merck & Co., Inc. (MRK)
Defactinib	Merus N.V. (MRUS)
degarelix	KYNTRA BIO INC. (KYNB)
degarelix	GH Research PLC (GHRS)
Erbitux®	Amneal Pharmaceuticals, Inc. (AMRX)
Eribulin	Merus N.V. (MRUS)
Eribulin Mesylate	Merus N.V. (MRUS)
Etoposide	ADMA BIOLOGICS, INC. (ADMA)
goserelin	GH Research PLC (GHRS)
goserelin	GH Research PLC (GHRS)
goserelin	KYNTRA BIO INC. (KYNB)
Inotuzumab Ozogamicin	AXIM BIOTECHNOLOGIES, INC. (AXIM)
isatuximab iv	Sanofi (SNY)
isatuximab sc	Sanofi (SNY)
Leucovorin	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Leucovorin Calcium	AXIM BIOTECHNOLOGIES, INC. (AXIM)
leuprolide	GH Research PLC (GHRS)
leuprolide	GH Research PLC (GHRS)
Leuprolide	KYNTRA BIO INC. (KYNB)
Liposome-encapsulated Daunorubicin-Cytarabine	Merus N.V. (MRUS)
montelukast	Sanofi (SNY)
Montelukast	Sanofi (SNY)
mosunetuzumab	GH Research PLC (GHRS)
nPulse Cardiac Catheter System	Pulse Biosciences Inc Common Stock (DE) (PLSE)
Ofatumumab	ENANTA PHARMACEUTICALS INC (ENTA)
osimertinib	GH Research PLC (GHRS)
pds0101	PDS Biotechnology Corp (PDSB)
Pegaspargase	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Pemetrexed Disodium	ADMA BIOLOGICS, INC. (ADMA)
ramucirumab	GH Research PLC (GHRS)
Relugolix	Myovant Sciences Ltd. (MYOV)
Relugolix Combination Tablet	Myovant Sciences Ltd. (MYOV)
Rescue Medication	Merus N.V. (MRUS)
RPH-002	Amneal Pharmaceuticals, Inc. (AMRX)
SYS6010	Merus N.V. (MRUS)
tepotinib	GH Research PLC (GHRS)
Tocilizumab	ENANTA PHARMACEUTICALS INC (ENTA)
triptorelin	GH Research PLC (GHRS)
triptorelin	GH Research PLC (GHRS)
Venetoclax	ENANTA PHARMACEUTICALS INC (ENTA)
vincristine liposomal	GH Research PLC (GHRS)
Vinorelbine Tartrate	Merus N.V. (MRUS)

Phase 2(85)

Drug	Company
Adavosertib	ADMA BIOLOGICS, INC. (ADMA)
Amivantamab and Recombinant Human Hyaluronidase	FATE THERAPEUTICS INC (FATE)
Asparaginase Erwinia chrysanthemi	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Bortezomib	Structure Therapeutics Inc. (GPCR)
brimonidine tartrate ophthalmic solution eye drops	AbbVie Inc. (ABBV)
Capsaicin Transmucosal Oral Film	Crinetics Pharmaceuticals, Inc. (CRNX)
CardiolRx	Cardiol Therapeutics Inc. (CRDL)
Carfilzomib	FATE THERAPEUTICS INC (FATE)
Carfilzomib	Crinetics Pharmaceuticals, Inc. (CRNX)
Celecoxib	Black Diamond Therapeutics, Inc. (BDTX)
Celecoxib	AIM ImmunoTech Inc. (AIM)
Cetuximab	Structure Therapeutics Inc. (GPCR)
Cetuximab	ImmunityBio, Inc. (IBRX)
CLD-101 (NeuroNova™)	Calidi Biotherapeutics Inc. (CLDI)
Clofarabine	Arbutus Biopharma Corp (ABUS)
Clofarabine	Structure Therapeutics Inc. (GPCR)
Clofarabine	ENANTA PHARMACEUTICALS INC (ENTA)
cylembio	IO Biotech, Inc. (IOBT)
Cytarabine	AIM ImmunoTech Inc. (AIM)
Dacarbazine or Temozolomide	PTC THERAPEUTICS, INC. (PTCT)
Daratumumab and Recombinant Human Hyaluronidase	Crinetics Pharmaceuticals, Inc. (CRNX)
Daratumumab and Recombinant Human Hyaluronidase	FATE THERAPEUTICS INC (FATE)
Dostarlimab	Merus N.V. (MRUS)
erlotinib	CG Oncology, Inc. (CGON)
Etoposide	Structure Therapeutics Inc. (GPCR)
Etoposide	AIM ImmunoTech Inc. (AIM)
etoposide phosphate	AIM ImmunoTech Inc. (AIM)
Fenofibric acid	AIM ImmunoTech Inc. (AIM)
Fenofibric acid	Black Diamond Therapeutics, Inc. (BDTX)
GSK5764227	Merus N.V. (MRUS)
Histrelin	KYNTRA BIO INC. (KYNB)
hu14.18k322a	GH Research PLC (GHRS)
hu14.18K322A	CG Oncology, Inc. (CGON)
ict-121	EOM Pharmaceutical Holdings, Inc. (IMUC)
KPL-387	Kiniksa Pharmaceuticals International, plc (KNSA)
Leuprolide	ENANTA PHARMACEUTICALS INC (ENTA)
Lomustine	ADMA BIOLOGICS, INC. (ADMA)
lubricating eye drops	AbbVie Inc. (ABBV)
mb-cart19.1	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
Mirvetuximab Soravtansine	AbbVie Inc. (ABBV)
n803	GH Research PLC (GHRS)
N803	CG Oncology, Inc. (CGON)
NAI	FATE THERAPEUTICS INC (FATE)
NAI	Amneal Pharmaceuticals, Inc. (AMRX)
neo100	NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
nuzefatide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
Ofatumumab	Filana Therapeutics Inc. (FLNA)
Ofatumumab	Structure Therapeutics Inc. (GPCR)
Ofatumumab	Merus N.V. (MRUS)
Olaparib	ADMA BIOLOGICS, INC. (ADMA)
onvansertib	Cardiff Oncology, Inc. (CRDF)
Onvansertib (Onv)	Cardiff Oncology, Inc. (CRDF)
palifosfamide	Alaunos Therapeutics, Inc. (TCRT)
PD-L1 t-haNK	FATE THERAPEUTICS INC (FATE)
PD-L1 t-haNK	Amneal Pharmaceuticals, Inc. (AMRX)
polatuzumab vedotin	GH Research PLC (GHRS)
Pomalidomide	FATE THERAPEUTICS INC (FATE)
Pomalidomide	Crinetics Pharmaceuticals, Inc. (CRNX)
Pomalidomide	Coeptis Therapeutics Holdings Inc. (COEP)
PRGN-2009	PRECIGEN, INC. (PGEN)
PRGN-2012	PRECIGEN, INC. (PGEN)
Raludotatug Deruxtecan	Merck & Co., Inc. (MRK)
REC-3964	RECURSION PHARMACEUTICALS, INC. (RXRX)
Regorafenib	MACROGENICS INC (MGNX)
Relugolix	ENANTA PHARMACEUTICALS INC (ENTA)
Relugolix	KYNTRA BIO INC. (KYNB)
reyobiq	PLUS THERAPEUTICS Inc. (PSTV)
Sacituzumab Govitecan	Amneal Pharmaceuticals, Inc. (AMRX)
sargramostim	GH Research PLC (GHRS)
Sargramostim	CG Oncology, Inc. (CGON)
stenoparib	Allarity Therapeutics, Inc. (ALLR)
stenoparib (formerly E7449)	Allarity Therapeutics, Inc. (ALLR)
Teclistamab	FATE THERAPEUTICS INC (FATE)
Teclistamab	Crinetics Pharmaceuticals, Inc. (CRNX)
Teclistamab	Coeptis Therapeutics Holdings Inc. (COEP)
Temozolomide	BioNTech SE (BNTX)
Temozolomide	PTC THERAPEUTICS, INC. (PTCT)
Temozolomide Oral Product	PTC THERAPEUTICS, INC. (PTCT)
Thalidomide	AIM ImmunoTech Inc. (AIM)
Thalidomide	Black Diamond Therapeutics, Inc. (BDTX)
triptorelin	KYNTRA BIO INC. (KYNB)
Vincristine Sulfate Liposome	Merus N.V. (MRUS)
Vincristine Sulfate Liposome	Structure Therapeutics Inc. (GPCR)
vintafolide	ENDOCYTE INC (ECYT)
vtx2735	Ventyx Biosciences, Inc. (VTYX)

Phase 1(48)

Drug	Company
abi-1179	ASSEMBLY BIOSCIENCES, INC. (ASMB)
ABI-1179 (1179)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
abi-5366	ASSEMBLY BIOSCIENCES, INC. (ASMB)
ABI-5366 (5366)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
adxs-504	OLD AYALA, INC (AYLA)
ADXS-504	Ayala Pharmaceuticals, Inc. (ADXS)
BI 770371	Amneal Pharmaceuticals, Inc. (AMRX)
Birinapant	IGM Biosciences, Inc. (IGMS)
BP1001-A	BIO-PATH HOLDINGS, INC. (BPTH)
Bridging Therapy	Filana Therapeutics Inc. (FLNA)
CAN-3110	Candel Therapeutics, Inc. (CADL)
Carfilzomib	Coeptis Therapeutics Holdings Inc. (COEP)
Cemiplimab	Actinium Pharmaceuticals, Inc. (ATNM)
Cytarabine	Accustem Sciences Inc. (ACUT)
Daratumumab and Recombinant Human Hyaluronidase	Coeptis Therapeutics Holdings Inc. (COEP)
Etoposide Phosphate	Accustem Sciences Inc. (ACUT)
imgn151	ImmunoGen, Inc. (IMGN)
kros 201	Kairos Pharma, LTD. (KAPA)
LDE225	Novartis AG (NVS)
linoserpaturev	Candel Therapeutics, Inc. (CADL)
lira-cel	Anixa Biosciences Inc (ANIX)
lyt-200	PureTech Health plc (PRTC)
mb-101	Fortress Biotech Inc. (FBIO)
mb-101	MUSTANG BIO, INC. (MBIO)
mb-108	MUSTANG BIO, INC. (MBIO)
mb-108	Fortress Biotech Inc. (FBIO)
mb-108	Fortress Biotech Inc. (FBIO)
mb-109	Fortress Biotech Inc. (FBIO)
Mitoxantrone Hydrochloride	Accustem Sciences Inc. (ACUT)
Mogamulizumab	Filana Therapeutics Inc. (FLNA)
nana-val	Viracta Therapeutics, Inc. (VIRX)
Natural Killer Cell Therapy	Filana Therapeutics Inc. (FLNA)
onc206	CHIMERIX INC (CMRX)
Onivyde	PTC THERAPEUTICS, INC. (PTCT)
PRGN-2012 - Phase I; Dose Level 1	PRECIGEN, INC. (PGEN)
PRGN-2012 - Phase I; Dose Level 2	PRECIGEN, INC. (PGEN)
PRGN-2012 - Phase II; Dose Level 2	PRECIGEN, INC. (PGEN)
PRGN-3005	PRECIGEN, INC. (PGEN)
PRGN-3006	PRECIGEN, INC. (PGEN)
Rintatolimod	Merck & Co., Inc. (MRK)
Rintatolimod	Merus N.V. (MRUS)
Selvigaltin	Coeptis Therapeutics Holdings Inc. (COEP)
Selvigaltin	FATE THERAPEUTICS INC (FATE)
Talazoparib	PTC THERAPEUTICS, INC. (PTCT)
Tocilizumab	ADMA BIOLOGICS, INC. (ADMA)
Venetoclax	ADMA BIOLOGICS, INC. (ADMA)
VTP-850	Barinthus Biotherapeutics plc. (BRNS)
xmt-2056	Mersana Therapeutics, Inc. (MRSN)

Preclinical(2)

Drug	Company
225ac-psma-62	POINT Biopharma Global Inc. (PNT)
cp101	Finch Therapeutics Group, Inc. (FNCH)

Unknown(1)

Drug	Company
tafinlar/mekinist	Novartis AG (NVS)

BLA Filed(1)

Drug	Company
dordaviprone	CHIMERIX INC (CMRX)

Phase 1/Phase 2(8)

Drug	Company
[203pb]vmt01	Perspective Therapeutics, Inc. (CATX)
[212pb]vmt01	Perspective Therapeutics, Inc. (CATX)
[68ga]ga-neob	Novartis AG (NVS)
micvotabart pelidotin	Pyxis Oncology, Inc. (PYXS)
miransertib	ARQULE INC (ARQL)
Temozolomide capsule	UNITED THERAPEUTICS Corp (UTHR)
tqb2922	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
VMT01	Perspective Therapeutics, Inc. (CATX)

Phase 2/Phase 3(1)

Drug	Company
hb-202/hb-201 alternating 2-vector therapy	HOOKIPA Pharma Inc. (HOOK)

Phase 4(15)

Drug	Company
[177lu]lu-neob	Novartis AG (NVS)
Abiraterone	KYNTRA BIO INC. (KYNB)
Abiraterone acetate 250 mg or 500 mg tablets	KYNTRA BIO INC. (KYNB)
AL	UNITED THERAPEUTICS Corp (UTHR)
Apalutamide	KYNTRA BIO INC. (KYNB)
Clofarabine	Filana Therapeutics Inc. (FLNA)
Darolutamide	KYNTRA BIO INC. (KYNB)
Induction therapy	Filana Therapeutics Inc. (FLNA)
Leuprolide	Myovant Sciences Ltd. (MYOV)
Niraparib oral capsule	UNITED THERAPEUTICS Corp (UTHR)
Sacubitril-valsartan	ENANTA PHARMACEUTICALS INC (ENTA)
saruparib	ASTRAZENECA PLC (AZN)
toripalimab	Coherus Oncology, Inc. (CHRS)
Valsartan	ENANTA PHARMACEUTICALS INC (ENTA)
Zopapogene imadenovec	PRECIGEN, INC. (PGEN)

Compare drugs

apixaban vs arcalyst apixaban vs avmapki fakzynja co-pack apixaban vs brexafemme

Frequently asked questions

How many drugs are in development for Recurrent?

BioSniper tracks 240 drugs in development for Recurrent across 91 companies.

How many clinical trials target Recurrent?

There are 3 clinical trials targeting Recurrent tracked by BioSniper.

Deep-dive into Recurrent

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis